Nasal high-flow oxygen therapy in ICU: A before-and-after study

Fealy, Nigel; Osborne, Clare; Eastwood, Glenn M; Glassford, Neil J; Hart, Graeme K; Bellomo, Rinaldo

doi:10.1016/j.aucc.2015.05.003

Cited by 9 publications

(4 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fealy et al studied ICU patients treated with a HFNC ( n = 35) versus historical controls treated with a high-flow face mask ( n = 48). The device cost per patient was reduced from $32.56 to $17.62 [ 49 ].…”

Section: Introductionmentioning

confidence: 99%

A Systematic Review of the High-flow Nasal Cannula for Adult Patients

2018

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

A Systematic Review of the High-flow Nasal Cannula for Adult Patients

2018

View full text Add to dashboard Cite

show abstract

“…Oxygen is a therapeutic agent mostly used in NICUs, and similar to any other medical intervention its complications, administration and home monitoring after discharge must be taken into account. In order to manage oxygen therapy complications and proper administration, the standards of care must be applied (10,11). Oxygen therapy elevates blood oxygen and improves the cardiopulmonary function by supplying enough oxygen to the tissues and inhibiting the accumulation of lactic acid (9).…”

Section: Introductionmentioning

confidence: 99%

Evaluation of adherence to oxygen therapy standards before, during and after oxygen hood administration

Kord

Tali

Karharoudy

2015

J Nurs Midwifery Sci

View full text Add to dashboard Cite

Background and Purpose: Oxygen therapy is one of the common treatments for neonates with cardiopulmonary disease. The aim of this study was to evaluate adherence to oxygen therapy standards by nurses before, during and after using oxygen hood. Methods: In this cross-sectional study, 250 cases of nursing care were evaluated before, during and after administration of oxygen hood therapy in preterm infants. The observations were conducted according to the standards of the neonatal intensive care units (NICU) of hospitals affiliated to the Ahvaz University of Medical Sciences. The data collection tools included a self-designed checklist for nursing audit evaluating the performance of NICU nurses working by neonatal oxygen hood, and a demographic profile checklist. The data were analyzed by Chi-square and Spearman tests, using SPSS version 18. Results: The results demonstrated insufficient adherence to the standards of oxygen therapy by 90% of the nurses before neonatal oxygen hood. Moreover, regarding the mentioned standards, 84% and 99.2% of the nurses had moderate and poor performance during and after oxygen therapy, respectively. Conclusion: Considering the poor performance of the NICU nurses before, during and after oxygen therapy, appropriate supervision and training programs for nurses is recommended to promote their capabilities in this regard.

show abstract

“…The authors reported a consumable cost saving per patient with HFOT associated with a significant difference in the number of intubations, more patients discharged from ICU and fewer patients using three or more oxygen delivery devices. 21 These studies are the only two papers that report costs in the literature. Our study coincides with the main conclusion of both that HFOT is cost-saving.…”

Section: Discussionmentioning

confidence: 99%

“…Studies from United Kingdom and Australia show that HFOT reduced costs by reducing LOS and overall resources. 20 , 21 In this study, we aimed to measure cost differences between HFOT and COT in patients with severe COVID-19 in three Colombian hospitals, based on data from a multicenter clinical trial. 17 …”

Section: Introductionmentioning

confidence: 99%

Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID-19 in Colombia: Data from a Randomized Clinical Trial

Prada,

Garcia-Garcia,

Ospina-Tascón

et al. 2023

CEOR

View full text Add to dashboard Cite

Background A randomized clinical trial (HiFlo-COVID-19 Trial) showed that among patients with severe COVID-19, treatment with high-flow oxygen therapy (HFOT) significantly reduced the need for invasive mechanical ventilation support and time for clinical recovery compared with conventional oxygen therapy (COT). However, the cost of this strategy is unknown. Objective We examined total cost of HFOT treatment compared with COT in real-world setting. Methods We conducted a post-trial-based cost analysis from the perspective of a managed competition healthcare system, using actual records of billed costs. Cost categories include general ward, intensive care unit, procedures, imaging, laboratories, medications, supplies, and others. Results A total of 188 participants (mean age 60, 33% female) were included. Average costs (and standard deviation) in the HFOT group were USD $7992 (7394) and in the COT group USD $ 10,190 (9402). Differences, however, did not reach statistical significance (P=0.093). However, resource use was always less costly for the HNFO group, with an overall percentage decrease of 27%. Two categories make up 72% of all savings: medications (41%) and intensive care unit (31%). Conclusion For patients in ICU with severe COVID-19 the cost of treatment with HFOT as compared to COT is likely to be cost-saving due to less use of medications and length of stay in ICU.

show abstract

Nasal high-flow oxygen therapy in ICU: A before-and-after study

Cited by 9 publications

References 27 publications

A Systematic Review of the High-flow Nasal Cannula for Adult Patients

A Systematic Review of the High-flow Nasal Cannula for Adult Patients

Evaluation of adherence to oxygen therapy standards before, during and after oxygen hood administration

Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID-19 in Colombia: Data from a Randomized Clinical Trial

Contact Info

Product

Resources

About